Memory T cells mount an accelerated response upon re-challenge but are heterogeneous in phenotype and function. Traditionally memory T cells were classified into central memory, effector memory and terminally differentiated effector memory (T EMRA ) cells based on expression of CCR7 and CD45RA. Functional heterogeneity even within these subsets demonstrated the need for more suitable markers. We applied bulk and single gene expression profiling of human CD4 + memory T cells and identified surface markers, KLRB1, KLRG1, GPR56 and KLRF1, allowing classification into "low", "high" or "exhausted" cytokine producers. In contrast to common understanding KLRG1 expression was not associated with exhaustion and highest production of multiple cytokines was observed in KLRB1 + KLRG1 + GPR56 + T cells. Only additional KLRF1
INTRODUCTION

CD4
+ helper T cells coordinate the immune response against invading pathogens and malignancies (1) (2) (3) (4) (5) . However, they also play a pathological role in the development of various inflammatory and/or autoimmune disorders (6, 7) .
In association to their differentiation state, CD4 + T cell populations vary in their migratory behaviour, cytokine production potential, proliferation capacity and effector function and thus, in their overall potential to provide immediate protection upon antigen encounter (8, 9) . Naïve T cells (T N ) develop in the thymus and migrate into secondary lymphoid organs where, upon primary antigen encounter, they provide delayed effector functions and differentiate into memory T cells (10, 11) . In contrast, memory T cells show an accelerated and intensified response to antigen re-encounter, which results in rapid antigen clearance. Recent findings have shown that the functional repertoire of memory T cells is manifold and subpopulations varying in their location, protection capacity and longevity have been described (10, 11) .
Due to this complexity, researchers have urged to identify phenotypic properties which help to distinguish different memory T cell subpopulations (12, 13) . Based on the expression patterns of lymph node homing receptors (CD62L or CCR7) and CD45 splice variants, CD8 + and CD4 + T cells were classified into CD45RA + CCR7 + naïve (T N ), CD45RA -CCR7 + central memory (T CM ), CD45RA -CCR7 -effector memory (T EM ) and CD45RA + CCR7 -terminally differentiated effector memory (T EMRA ) cells (14) (15) (16) . While the developmental relationship between these memory subsets is still a matter of debate, our own recent epigenomic and transcriptomic characterizations of human circulating CD4 + T cell subsets support a linear differentiation model in the order of T N -T CM -T EM -T EMRA cells (17) .
T CM cells circulate between blood and lymphoid compartments like T N cells and have a high proliferation potential and self-renewal capacity. Therefore, they form a long-lasting reservoir of memory T cells but display only limited protection potential as their effector cytokine production after re-activation is limited. Both CCR7 -T EM and T EMRA subsets are excluded from lymphatic organs and migrate via the blood to peripheral tissues (15, 16) where they participate in immediate protection from re-occurring infections (9, 18) . This is mediated by a heterogeneous, but generally high multi-functional cytokine production potential of T EM cells (9) . However, contrasting findings have been published for T EMRA cells, reporting either high or low cytokine production potential. The latter one being attributed to an "exhausted" phenotype of the terminally differentiated T EMRA population (9, (19) (20) (21) . Indeed, T EMRA cells have characteristics of end-stage differentiation and thus a very low proliferative potential (19, 21, 22) , they do acquire KLRG1 and CD57 but loose CD28 and CD27 expression (21) . However, acquisition of CD57 and loss of CD28 or CD27 expression is not exclusive for T EMRA cells but also observed for some T EM cells (22, 23) . These results demonstrate, that T EM and T EMRA populations defined by the CD45RA/CCR7-classification seem to represent heterogeneous pools of cells which are functionally and phenotypically not clearly defined and distinguishable. This is particularly true for CD4 + memory T cells.
Due to their high pro-inflammatory cytokine production potential, CD4 + memory T cells are key promoters of chronic inflammation when the physiological regulatory circuits fail. Therefore, it is not surprising that increased proportions and absolute numbers of T EM and also T EMRA cells have been observed in patients suffering from chronic inflammatory diseases (24, 25) .
However, due to the high cellular heterogeneity and possible partial functional overlap of these two populations, it seems likely that a functionally similar T cell subset with high cytokine secretion properties might be driving the chronic inflammation irrespective of their CD45RA/CCR7
phenotype. Therefore, in this study, we aimed at characterizing the true functional heterogeneity of human CD4 + T cell subsets at the single cell level including the identification of reliable surface markers correlating with their cytokine production properties, contributing to inflammatory diseases.
We addressed these questions by performing gene expression profiling of purified human CD4 + T N , T CM , T EM and T EMRA cells from peripheral blood of first healthy individuals followed by single cell expression studies and identified different combinations of the surface markers KLRB1, KLRG1, GPR56 and KLRF1 suitable to describe the development of human CD4 + memory T cells with varying cytokine production potential. Co-expression of KLRB1 with either KLRG1 or GPR56
or co-expression of all three markers was associated with high TNF-a/IFN-g co-expression potential while additional acquisition of KLRF1 expression during terminal differentiation resulted 5 in a reduction of the cytokine production capacity. This novel classification allowed a more precise definition of functional states of "high" and "exhausted" cytokine producers as compared to the classical T EM or T EMRA gating, respectively. Importantly, this could be confirmed for blood and especially intrahepatic CD4 + T cells from patients with inflammatory liver diseases. With these data we introduce a novel surface marker classification scheme which more precisely defines functionally distinct memory T cell subsets as compared to the CD45RA/CCR7-based categorisation. These results highlight that human memory T cell populations especially within inflamed tissues are heterogeneous and require detailed characterizations on the single cell level to identify disease-driving subsets as targets for novel therapeutic approaches.
RESULTS
Identification of overlapping gene signatures enriched in human CD4 + T EM and T EMRA cells
In order to get more insights into common versus different phenotypic and functional properties of CD4 + T EM and particularly T EMRA cells we performed a comparative gene expression profiling of sorted CD4 + T N , T CM , T EM and T EMRA cells from peripheral blood of healthy individuals. We focussed on genes encoding cell surface proteins in order to identify phenotypic markers associated with distinct functional properties (e.g. cytokine production potential) of different T cell subsets. Figure 1a shows a heatmap of genes identified through an intersection analysis between T EMRA vs. and CD300C. In addition, genes encoding proteins regulating cell migration and adhesion such as S1PR5, CXC3CR1 and ADGRG1 (also known as GPR56) were highly up-regulated. The microarray analysis also identified genes, whose expression was specifically increased in T EM cells such as genes encoding c-Kit or the killer-like receptor KLRB1 (see also supplementary table 1 -last 6 genes). Taken together, we could identify a set of genes encoding surface markers, which were significantly higher expressed in more differentiated human CD4 + T EM and T EMRA cells.
Heterogeneity in candidate gene expression within T EMRA and T EM cells
We used the identified CD4 + T EM -and T EMRA -specific genes to investigate, whether their expression was homogeneous or could be attributed to certain cell subsets within CD4 + T EM -and When comparing the single cell expression data on mRNA and protein level, we observed nearly identical frequencies for GPR56 and KLRG1 expression (figure 2b). In contrast, proportion of For this, we applied the recently described wanderlust algorithm to construct a trajectory of CD4 + T cell differentiation based on the classical surface marker CD45RA and CCR7 and our identified surface marker set (26) . Using CD45RA and CCR7 expression we defined CD45RA + CCR7 + (T N ) cells as the "initiator" and CD45RA + CCR7 -(T EMRA ) cells as the "terminal" cells. We then examined the relative expression pattern of our identified marker but also intracellular TNF-a and IFN-g along the developmental trajectory by plotting them against the wanderlust axis (figure 3c). According to this analysis, KLRB1 expression was the first marker to be acquired during CD4 + memory T cell differentiation, a result which is nicely confirmed by our bulk and single cell-based gene expression analyses (figures 1 and 2). Subsequently, cells started to up-regulate KLRG1 followed by a nearly induction of GPR56. KLRF1 expression was only acquired at a late stage during memory T cell differentiation. Interestingly, simultaneously to the up-regulation of KLRB1 T cells obtained the potential to produce TNF-a and with a slight delay also IFN-g. Whereas KLRB1 and KLRG1
showed a nearly constant increase in expression during differentiation, GPR56 and KLRF1 expression followed a two-phase pattern. Late stage differentiated CD45RA re-expressing CD4 + T cells acquired very high KLRG1, GPR56 and KLRF1 expression but a reduction in KLRB1 expression concurrent with a decline in TNF-a and IFN-g production.
Combinations of different KLRs and GPR56 allow refined description of memory CD4 + T cell states and define magnitude of cytokine production potential
From our wanderlust analysis we concluded a progressive acquisition of our surface markers during memory T cell differentiation in the following order: KLRB1, KLRG1, GP56, KLRF1. Based on this, we analysed whether the T cell subsets defined by this new scheme would indeed recapitulate or even refine the known correlation to cytokine expression potential from "low"
(classically gated T N cells) to "high" (T EM cells) and finally to "exhausted" (T EMRA cells, Fig. 4a , top row).
To this end we defined the following subsets within total CD4 + T cells: 1) no marker expression = -subsets displayed only minor differences in cytokine production potential.
In fact, the KLRB1 -subsets (depicted in lighter colours in figure 4a) recapitulated the progressive acquisition of cytokine expression potential with memory T cell differentiation and terminal exhaustion with acquisition of the KLRF1 marker (figure 4a). Based on these results, we conclude that the combinatory expression profile of KLRB1, KLRG1, GPR56 and KLRF1 allows a refined classification of memory T cell subsets along their differentiation line and correlating to their functional state judged from their cytokine expression potentials "low", "medium", "high" and "exhausted" (figure 4b Having revealed that T EM cells contain less TNF-a & IFN-g co-producing cells as compared to the most potent subsets with the new classification, we wondered whether indeed T EM cells are composed of different subsets according to our KLRF/GPR56-based definition. Indeed, although the "high" cytokine producing subsets made up the majority of T EM cells, populations with a "low"
or "exhausted" functional state were also present, which may explain the overall lower cytokine production potential in T EM cells (figure 4c). Furthermore, T EMRA cells were composed of mainly "exhausted" populations with some of the other subsets remaining (figure 4c), but showed in general a lower cytokine production potential (figure 4b). Thus, the refined classification of memory T cells according to the KLR/GPR56 scheme reveals functional heterogeneity in the classical T EM and T EMRA subsets with partially overlapping composition.
Novel KLR/GPR56-classification reveals reduction in functionally exhausted memory T cells and increase in cytokine producers in the liver compared to the peripheral blood.
In recent years it became clear that significant phenotypical and functional differences exist between circulating and intra-tissue T cells (27, 28) . We therefore studied our newly defined which also showed a strong enrichment for GPR56, KLRF1 and partially KLRG1 expressing cells.
This indicated that there was a qualitative difference between liver and blood-derived T EM and T EMRA cells. Indeed, the proportion of GPR56, KLRF1 and partially KLRG1 expressing T EM cells showed a tendency to be lower in liver samples, whereas the opposite was true for the proportion of KLRB1 expressing T EM cells (figure 5c). and T EMRA cells as we also observed transcription in T CM cells.
Our four identified surface marker, KLRB1, KLRG1, GPR56 and KLRF1, were all first described in relation to their high expression in NK cells (18, (39) (40) (41) (42) indicating similarities between NK cell differentiation and memory/effector T cell development.
The C-type lectin KLRB1 also known as CD161 has been shown to be expressed by CD4 + and CD8
+ T cells. For CD4 + T cells, KLRB1 expression was mainly ascribed to IL-17 producing Th17 cells (43).
However, other recent publications identified also broader KLRB1 expression across different T cell lineages expressing e.g. IL-17 or TNF-a/IFN-g which is in agreement with our findings (44-46).
For NK cells KLRB1 ligation is generally accepted to be inhibitory (44). In contrast, for T cells inhibitory as well as costimulatory roles have been proposed (44). This might explain our results
as acquisition of KLRB1 expression was associated with a first significant increase in cytokine producing CD4 + T cells. Interestingly, we did observe differences between KLRB1 transcription and protein expression. Whereas, KLRB1 transcription was mainly limited to T CM and T EM cells, protein expression was observed for T CM , T EM and T EMRA cells and not down-regulated even upon acquisition of an "exhausted" cytokine production fate.
The killer cell lectin-like G1 (KLRG1) is a marker for T cell senescence as expressing cells have limited proliferative capacity (19, 21) . However, KLRG1 expressing T cells are not exhausted as they display cytokine production and cytotoxic potential (47) . KLRG1 expression is supposed to be limited to tissue-homing and thus T EM and T EMRA cells (8, 28, (48) (49) (50) . Our own data showed that also a significant proportion (»22%) of CCR7 expressing T CM cells KLRG1 + . These findings are in agreement with other published reports showing that also T CM cells can express KLRG1 which was associated with increased production of effector cytokines of the expressing T CM cells (35) .
Indeed, also our results revealed a dramatic increase of cytokine production potential as soon as the T cells acquired KLRG1 expression. This again shows the superiority of our identified KLR/GPR56-based categorisation over the traditional CD45RA/CCR7-based system.
Already in the first report describing the NK cell triggering activity of KLRF1, also known as NKp80, its expression on a subset of T cells was observed (42) . In addition, it was shown that NKp80 ligation can augment CD3-stimulated degranulation and IFN-g secretion by effector memory CD8 + T cells (51) . This is contradictory to the here described results as KLRF1 acquisition was associated with a decline in cytokine production potential. However, our investigations were performed on CD4 + T cells, and for murine T cells distinct properties for CD4 + in comparison to CD8 + T cells were recently described (37) . It remains to be investigated whether KLRF1 plays an inhibitory role for human CD4 + memory T cell activation. Nevertheless, KLRF1 expression was able to identify memory CD4 + T cells with reduced cytokine production potential regardless of cohort (healthy control vs. patient) or tissue type origin.
GPR56 was shown to be expressed by cytotoxic NK and T lymphocytes including CD8 + , CD4 + and gd + T cells (41) . For NK cells an inhibitory role for GPR56 in controlling steady state activation by associating with the tetraspanin CD81 was revealed (52) . Similar to KLRF1, the role of GPR56 for stimulation-dependent production of cytokines by human CD4 + T cells is unknown and needs to be investigated in further studies.
Our findings of successive expression of several killer-like receptors and GPR56 concurrent to first increasing and finally declining cytokine production potential is completely in line with our previous findings on linear differentiation from T CM , via T EM and towards T EMRA cells (17) . There we detected an increase in global demethylation which could explain the successive expression pattern described here.
Finally, our results with increased T EM but decreased or equal T EMRA frequencies in liver in
comparison to blood is in agreement with recent descriptions on the spatial map of human T cell compartmentalization (11) . Although the authors did not investigate liver tissue, they reported also increased T EM frequencies within intestinal and lung tissues in comparison to blood whereas T EMRA frequencies did not vary. However, the here reported combinational expression pattern of KLRs and GPR56 challenge the analysis of overall T EM and T EMRA frequencies as analysis of KLRB1, KLRG1 and / or GPR56 expression versus final acquisition of KLRF1 seem to be superior to discriminate between "high" and "exhausted" cytokine producing cell subsets, which are decreased in intra-hepatic CD4 + T EM and T EMRA cells in comparison to their blood equivalents.
In summary our data reveal that identifying human CD4 + memory T cell populations based on the expression pattern of KLRB1, KLRG1, GPR56 and KLRF1 enables a better definition of functional states especially in peripheral tissues as compared to the classical CD45RA/CCR7-based categorisation. These findings will have enormous implications for clinical diagnostics, development of novel target-specific immune therapies as well as a better understanding of CD4 + memory T cell development and function. It will be interesting to see whether the here described combinational expression profile and functional subsets might aid improved prediction of disease progression in inflammatory diseases or therapeutic efficacy upon vaccination or checkpoint inhibition. were processed within an hour after retrieval.
MATERIALS AND METHODS
Peripheral
Isolation of peripheral blood mononuclear cells (PBMC). PBMC were isolated at room
temperature by density gradient centrifugation (Biocoll, Biochrom, Berlin, Germany) of heparinized blood diluted 1:2 in Phosphate-Buffered Saline (PBS) (Gibco, Thermo Fisher Scientific, Paisley, UK). Cell number was determined using a hemocytometer. Isolated PBMC were directly used for sorting, stimulation or were cryopreserved.
Isolation of intrahepatic lymphocytes (IHL).
Liver tissue was dissected into 1 mm³ fragments and digested with agitation (75-80 rpm) at 37 °C for 30 minutes in a digestive solution (2 % FCS, 0.6 % bovine serum albumin, 0.05 % collagenase type IV and 0.002 % DNAse I per 1 g tissue and 10ml).
Undissociated tissue was pressed through a steel sieve with a syringe plunger and dissolved in the same solution. Dissociated tissue was centrifuged at 500 x g. Tissue components were diluted in HBSS. The tissue suspension was centrifuged at 30 x g to separate and discard the formed hepatocyte-rich matrix. Still undissociated tissue was removed by filtration through 100 µm nylon mesh, leaving a cell suspension. Hepatocytes were removed using a 33 % Bicoll density gradient centrifugation. Red blood cells were lysed using water. Isolated intrahepatic lymphocytes were cryopreserved in liquid nitrogen. + T cells (CD4 microbeads, human, Miltenyi Biotec) were stained in MACS-buffer (PBS with 0.5% BSA and 2 mM EDTA) at a concentration of 2 x 10 8 cells per ml for surface expression using anti-CCR7-Alexa488 (GO43H7),
Antibody staining and T cell subset sorting. MACS-enriched CD4
anti-CD25-PE (M-A251), anti-CD45RA-PE-Cy7 (HI100), anti-CD127-APC (A019D5), anti-CD3-Alexa700 (UCHT1), anti-CD4-BV510 (OKT4), and anti-CD45R0-ECD (UCHL1, all from BioLegend).
Cells were washed and stained with DAPI.
Cells were sorted using a BD FACSAria TM II into the following CD4 + T cell subpopulations: Treg (CD25 high CD127 low ) and non-Treg:
and T EMRA (CD45RA + CCR7 -).
RNA microarray analysis.
Total RNA from sorted T cell populations was isolated using TRIzol (Thermo Fisher Scientific, Bremen, Germany). RNA quality and integrity were determined using the Agilent RNA 6000 Nano
Kit on the Agilent 2100 Bioanalyzer (Agilent Technologies). RNA was quantified by measuring A260nm on the ND-1000 Spectrophotometer (NanoDrop Technologies).
RNA Amplification and Labeling:
Sample labeling was performed as detailed in the "One-Color Microarray-Based Gene Expression
Analysis protocol (version 6.6, part number G4140-90040). Briefly, 10 ng of each total RNA samples was used for the amplification and labeling step using the Agilent Low Input Quick Amp Labeling Kit (Agilent Technologies). Yields of cRNA and the dye-incorporation rate were measured with the ND-1000 Spectrophotometer (NanoDrop Technologies).
Hybridization of Agilent Whole Mouse Genome Oligo Microarrays:
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